Erem, C. Et Al. 2015. Ischemia-modified albumin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress. ENDOCRINE JOURNAL , vol.62, no.6 , 493-501.

Erem, C., SÜLEYMAN, A. K., CİVAN, N., MENTEŞE, A., NUHOĞLU, İ., UZUN, A., ... Ersoz, H. Ö.(2015). Ischemia-modified albumin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress. ENDOCRINE JOURNAL , vol.62, no.6, 493-501.

Erem, CİHANGİR Et Al. "Ischemia-modified albumin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress," ENDOCRINE JOURNAL , vol.62, no.6, 493-501, 2015

Erem, CİHANGİR Et Al. "Ischemia-modified albumin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress." ENDOCRINE JOURNAL , vol.62, no.6, pp.493-501, 2015

Erem, C. Et Al. (2015) . "Ischemia-modified albumin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress." ENDOCRINE JOURNAL , vol.62, no.6, pp.493-501.

@article{article, author={CİHANGİR EREM Et Al. }, title={Ischemia-modified albumin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress}, journal={ENDOCRINE JOURNAL}, year=2015, pages={493-501} }